Related Experiment Video
Updated: May 16, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Hospitalizations for cardiovascular disease in African Americans and whites with HIV/AIDS
Christine U Oramasionwu1, Gene D Morse, Kenneth A Lawson
1UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
Insights
African Americans with HIV/AIDS face a 45% higher risk of cardiovascular disease (CVD) hospitalizations compared to whites. This study highlights racial disparities in CVD hospitalizations among HIV/AIDS patients.
Area of Science:
- Public Health
- Epidemiology
- Cardiovascular Medicine
Background:
- Therapeutic advances have shifted HIV/AIDS hospitalizations towards cardiovascular disease (CVD).
- Limited data exist on racial disparities in CVD hospitalizations among individuals with HIV/AIDS.
- Understanding these disparities is crucial for targeted interventions.
Purpose of the Study:
- To evaluate the association between race and CVD hospitalization in African Americans versus whites with HIV/AIDS.
- To compare the types of CVD-related hospitalizations between these racial groups.
Main Methods:
- Observational, retrospective study using US National Hospital Discharge Surveys (1996-2008).
- Analyzed approximately 1.5 million hospital discharges.
- Controlled for potential confounders including chronic kidney disease, age, region, and insurance.
Main Results:
- African Americans with HIV/AIDS had 45% higher odds of CVD-related hospitalization (OR=1.45).
- Increased odds associated with chronic kidney disease, age ≥50, Southern US region, and Medicare coverage.
- African Americans had more heart failure/hypertension hospitalizations, fewer stroke/coronary heart disease hospitalizations than whites.
Conclusions:
- African Americans with HIV/AIDS experience significantly higher odds of CVD-related hospitalization compared to whites.
- The types of CVD hospitalizations differ notably between African American and white patients with HIV/AIDS.
- Findings underscore the need for race-specific strategies in managing CVD in the HIV/AIDS population.
Abstract:
Therapeutic advances have resulted in an epidemiological shift in the predominant causes of hospitalization for patients with HIV/AIDS. An emerging cause for hospitalization in this patient population is cardiovascular disease (CVD); however, data are limited regarding how this shift affects different racial groups. The objective of this observational, retrospective study was to evaluate the association between race and hospitalization for CVD in African Americans and whites with HIV/AIDS and to compare the types of CVD-related hospitalizations between African Americans and whites with HIV/AIDS. Approximately 1.5 million hospital discharges from the US National Hospital Discharge Surveys for the years of 1996 to 2008 were identified. After controlling for potential confounders, the odds of CVD-related hospitalization in patients with HIV/AIDS were 45% higher for African Americans than whites (odds ratio [OR]=1.45, 95% CI, 1.39-1.51). Other covariates that were associated with increased odds of hospitalization for CVD included chronic kidney disease (OR=1.43, 95% CI, 1.36-1.51), age≥50 years (OR=3.22, 95% CI, 2.94-3.54), region in the Southern United States (OR=1.17, 95% CI, 1.11-1.23), and Medicare insurance coverage (OR=1.71, 95% CI, 1.60-1.83). Male sex was not significantly associated with the study outcome (OR=0.99, 95% CI, 0.96-1.02). Compared to whites with HIV/AIDS, African Americans with HIV/AIDS had more hospitalizations for heart failure and hypertension, but fewer hospitalizations for stroke and coronary heart disease. In conclusion, African Americans with HIV/AIDS have increased odds of CVD-related hospitalization as compared to whites with HIV/AIDS. Furthermore, the most common types of CVD-related hospitalizations differ significantly in African Americans and whites.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
